The Beta Agonist Lung Injury TrIal (BALTI)--prevention trial protocol.
BACKGROUND: Acute lung injury complicates approximately 25-30% of subjects undergoing oesophagectomy. Experimental studies suggest that treatment with beta agonists may prevent the development of acute lung injury by decreasing inflammatory cell infiltration, activation and inflammatory cytokine rel...
Main Authors: | Perkins, G, Park, D, Alderson, D, Cooke, M, Gao, F, Gates, S, Lamb, S, Mistry, D, Thickett, DR |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
The Beta Agonist Lung Injury TrIal (BALTI) - prevention trial protocol
by: Gates Simon, et al.
Published: (2011-03-01) -
Beta Agonist Lung Injury TrIal-2 (BALTI-2) trial protocol: a randomised, double-blind, placebo-controlled of intravenous infusion of salbutamol in the acute respiratory distress syndrome.
by: Perkins, G, et al.
Published: (2011) -
Beta Agonist Lung Injury TrIal-2 (BALTI-2) trial protocol: A randomised, double-blind, placebo-controlled of intravenous infusion of salbutamol in the acute respiratory distress syndrome
by: McCabe Chris, et al.
Published: (2011-05-01) -
Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome.
by: Gates, S, et al.
Published: (2013) -
Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome.
by: Gates, S, et al.
Published: (2013)